Commentary|Videos|January 23, 2025
Implications of New Multiple Sclerosis Criteria on Overlapping Autoimmune Conditions: Joseph Kuchling, MD
Fact checked by: Marco Meglio
At ECTRIMS 2024, the postdoctoral research assistant at Charité University Berlin discussed how the updated diagnostic criteria aim to address gaps in diagnosing and treating overlapping autoimmune conditions. [WATCH TIME: 4 minutes]
Advertisement
WATCH TIME: 4 minutes
"Hopefully, these new criteria will help us secure earlier diagnoses and treatments for these patients who are often caught between diagnoses."
Research has shown that some patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) exhibit clinical symptoms and T2-hyperintense MRI lesions resembling those seen with multiple sclerosis (MS). However, specific MRI characteristics of this overlap syndrome remain poorly understood. In a recent study conducted by lead author Joseph Kuchling, MD , and colleagues, findings confirmed that overlap with MS was common among patients with NMDARE. This suggests a potential pathophysiological link between the 2 conditions, highlighting the need for tailored diagnostic and therapeutic approaches to manage NMDARE and MS effectively.
Presented at the 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress , held September 18-20, in Copenhagen, Denmark, the study compared neuroimaging data from patients with overlapping NMDARE-MS and those with NMDARE alone, using data from the GErman NEtwork for Research of AuToimmune Encephalitis network. Key findings revealed that patients with the overlap syndrome exhibited atypical NMDARE symptoms, a conventional MRI lesion pattern typical of MS, rapid lesion progression, and MS-specific lesion features, such as the central vein sign, on 7T-MRI imaging.
At the Congress, Kuchling, a postdoctoral research assistant at Charité University Berlin, discussed these findings and their implications with NeurologyLive®. During the conversation, Kuchling emphasized how the evolving diagnostic criteria could significantly impact the management of patients with overlapping autoimmune and neurological conditions. He highlighted the need for healthcare systems to address the challenges faced by patients in the diagnostic gray area. Additionally, Kuchling underscored the importance of further research to refine follow-up care protocols to detect and manage underlying neurological diseases in patients initially diagnosed with autoimmune encephalitis.
REFERENCES
1. Kuchling J, Penner L, Fernandez Ceballos R, et al. NMDA Receptor Encephalitis and Multiple Sclerosis Overlap Syndrome - Part I: Clinical Findings and MRI Characteristics. Presented at ECTRIMS Congress; September 18-20, 2024; Copenhagen, Denmark. Scientific Session 1: New diagnostic criteria. Abstract 2310.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025
- NeurologyLive® Brain Games: September 14, 2025
September 14th 2025
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4